ReviewFrontiers in public health2026
Socio-economic impact of antimicrobial resistance in Pakistan: a comprehensive review.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) is an increasing public health and economic threat, with substantial consequences for low- and middle-income countries such as Pakistan. This review critically synthesizes peer-reviewed evidence on the socioeconomic impact of AMR in Pakistan and examines policy and implementation challenges linked to the National Action Plan on AMR. A structured PubMed search was conducted for studies published between January 2025 and April 2026, with the final search completed on 28 April 2026. Search terms included "antimicrobial resistance AND Pakistan," "AMR AND Pakistan AND National Action Plan," "antimicrobial resistance AND socioeconomic impact AND Pakistan," "antibiotic resistance AND healthcare costs AND Pakistan," and "AMR AND surveillance AND Pakistan." Following PRISMA-guided screening, 29 studies were included in the qualitative synthesis. The findings indicate rising resistance across multiple pathogens and settings, including enteric pathogens, respiratory organisms, multidrug-resistant Gram-negative bacteria, and resistant infections in hospital, community, and environmental contexts. Evidence from genomic and epidemiological studies shows persistent fluoroquinolone resistance and emerging azithromycin resistance, suggesting narrowing therapeutic options. The socioeconomic burden includes prolonged illness, increased diagnostic and treatment costs, longer hospital stays, productivity loss, and household financial strain. However, national cost-of-illness evidence remains limited, and available estimates are mainly derived from single-center studies. Policy gaps include fragmented surveillance, weak enforcement of prescription regulations, inconsistent antimicrobial stewardship, and limited public awareness. Strengthening integrated surveillance, improving regulatory enforcement, expanding vaccination strategies, and embedding AMR within health financing and public health planning are essential to reduce the long-term socioeconomic burden of AMR in Pakistan.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.